Massive MS registry launches to track treatment safety in real time
NCT ID NCT03291756
First seen Feb 22, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study is a large registry that will follow 1,000 adults with multiple sclerosis (MS) across North America. Researchers will collect data on how well approved MS treatments work and what side effects they cause in everyday medical practice. The goal is to better understand the disease, its complications, and current treatment patterns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.